Navigation Links
Strategies for Winning Clinical Investigators in a Competitive Marketplace
Date:5/1/2008

CHAPEL HILL, N.C., May 1 /PRNewswire/ -- Leading pharmaceutical companies and CROs agree that effective clinical investigator recruitment is part of the critical path in successful clinical trials and subsequent product launch. Clinical Trial Excellence: The Science and Art of Winning Investigators in a Competitive Marketplace illustrates proven techniques that speed clinical trial investigator recruitment and reduce the time to revenue.

To download a complimentary report summary, including sample best practices drawn from extensive primary research with executives at leading companies click the following or paste the link into your browser: http://www3.best-in-class.com/rr936.htm.

Companies that participated in this study are: Amersham; ALTANA Pharmaceuticals; Amgen; AAI Development; AstraZeneca; Biologicals International; Aventis; ICON; Baxter Healthcare; Parexel; Bristol-Myers Squibb; Panacos Pharmaceuticals; Eli Lilly and Company; Perlegen Sciences; GlaxoSmithKline; PPD Development; Human Genome Sciences; Janssen; PLIVA Pharmaceuticals; Pfizer; Roche; 3M Pharmaceuticals; America's Doctor; BBK Healthcare; Covance; PPD.

The report includes specific examples, more than 180 metrics, and recommendations on how to identify and close performance gaps. Additionally, this study reveals how your organization can:

-- Increase the attractiveness and credibility of studies through

effective positioning.

-- Identify key opinion leaders and investigators for protocol design

input and clinical trials.

-- Evaluate the commitment and qualifications of these investigators.

-- Create effective structures for both internal and external

accountability.

-- Partner with third parties to leverage clinical trial expertise.

To find out more about Best Practices Research and Consulting, please visit our website at http://www3.best-in-class.com/ or contact Grant Houston at 919-767-9182 or ghouston@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit http://www3.best-in-class.com/.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Best Practice Database: Valuable Strategies for Pharmaceutical Product Launches
2. Drugs in the pipeline: new therapies that could change treatment strategies
3. Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs
4. Tax Planning Ideas: Sound Strategies Protect Wealth, Advises Whitnell & Co.
5. Arthur J. Gallagher & Co. Acquires Life Insurance Strategies
6. Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps
7. Epilepsy advocates propose strategies to heighten treatment expectations
8. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
9. Bernard A. Krooks From the Special Needs Alliance to Talk Tax Strategies for Individuals With Disabilities Tomorrow on Good Morning America NOW
10. Adult Glioblastoma: Strategies, Challenges, and Opportunities
11. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: